Jennifer Carver is COO at LA JOLLA PHARMACEUTICAL CO (LJPC). They have made 5 open-market trades across 1 company since 2017, most recently 2026-08-17.
CIK 0001663163
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $146K since 2017, never a sale. Across 5 scored buys the stock is down 9.3% at ninety days, and 10.3 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 20% | 40% |
| Avg Move | -0.2% | -5.5% | -9.3% |
| Alpha | -1.9% | -7.1% | -10.3% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LJPC | BUY | 2019-01-09 | 2019-01-09 | $6.17 | $25K | -5.6% | -11.4% | +9.5% |
| LJPC | BUY | 2018-08-16 | 2018-08-20 | $20.90 | $21K | +1.7% | -4.9% | -35.1% |
| LJPC | BUY | 2018-02-23 | 2018-02-27 | $32.48 | $32K | +8.7% | -3.9% | +3.0% |
| LJPC | BUY | 2017-12-27 | 2017-12-29 | $33.22 | $33K | -7.6% | +10.4% | -9.3% |
| LJPC | BUY | 2017-03-02 | 2017-03-06 | $34.46 | $34K | +1.9% | -17.4% | -14.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.